Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial
Authors:
- Cinthya Ruiz-TagleCinthya Ruiz-Tagle
- Luis VillarroelLuis Villarroel
- Margarita BernalesMargarita Bernales
- Salvador Vargas-GarcíaSalvador Vargas-García
- Alejandra PizarroAPAlejandra Pizarro
- Patricia GarcíaPatricia García
- Kasim AllelKasim Allel
- Ruvandhi R NathavitharanaRuvandhi R Nathavitharana
- María Elvira BalcellsMaría Elvira Balcells
- 26 September 2025
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 82 (2) , 291-298
Abstract
Background: The duration of infectiousness following pulmonary tuberculosis treatment initiation remains uncertain. We aimed to assess whether a bundled intervention designed to decrease respiratory exposure was feasible and would reduce new tuberculosis infections in household contacts (HHCs). Methods: We conducted a pilot cluster-randomized controlled trial with a hybrid type 1 effectiveness-implementation design in Santiago, Chile. Random allocation was performed, and 2 healthcare districts were assigned to the intervention (n = 180 HHCs) and 1 to standard of care (n = 149 HHCs). Eligible participants were people newly diagnosed with pulmonary tuberculosis and their HHCs. The intervention included education, mask use, household ventilation, and nightly separation of tuberculosis patients, for 2 weeks. Intervention adherence was evaluated weekly. Effectiveness was assessed at the individual level with QuantiFERON®-TB Gold Plus (QFT) test conversions in HHCs at 12-week follow-up. Results: Between October 2021 and December 2023, 384 HHCs and 157 people with tuberculosis were enrolled. Overall, 56.3% of contacts were women, with a mean age of 34.6 years and a baseline QFT positivity of 32.3%. A total of 216 contacts had negative QFT result at baseline, with 179 (82.9%) completing follow-up. QuantiFERON®-TB Gold Plus conversions occurred in 11 (12.8%) and 10 (10.8%) HHCs from the intervention and control arms, respectively (incidence risk ratio 1.10, 95% CI .71–1.71, P = .849). Good adherence to the respiratory bundle was reported by 53% of participants on day 7 and 54% on day 14. Conclusions: Isolation and restrictive measures after tuberculosis treatment initiation proved challenging and did not reduce tuberculosis infections in HHCs, suggesting limited benefit for transmission control.Keywords
This publication has 27 references indexed in Scilit:
- A time-to-event modelling of sputum conversion within two months after antituberculosis initiation among drug-susceptible smear positive pulmonary tuberculosis patients: Implementation of internal and external validationTuberculosis, 2024
- Transmission characteristics in Tuberculosis by WGS: nationwide cross-sectional surveillance in ChinaEmerging Microbes & Infections, 2024
- National Tuberculosis Coalition of America Guidelines for Respiratory Isolation and Restrictions to Reduce Transmission of Pulmonary Tuberculosis in Community SettingsClinical Infectious Diseases, 2024
- Tuberculosis-associated depression: a population-based cohort study of people immigrating to British Columbia, Canada, 1985–2015Annals of Epidemiology, 2021
- Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?The Lancet Respiratory Medicine, 2021
- Household contact investigation to improve tuberculosis controlThe Lancet Infectious Diseases, 2019
- Vitamin D status and incidence of tuberculosis infection conversion in contacts of pulmonary tuberculosis patients: a prospective cohort studyEpidemiology and Infection, 2014
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Patterns of intra-cluster correlation from primary care research to inform study design and analysisJournal of Clinical Epidemiology, 2004
- Dramatic decrease in tuberculin skin test conversion rate among employees at a hospital in New York City*1American Journal of Infection Control, 1995